ArticleFrontiers in oncology2021

STK3-ALK, a Novel ALK Rearrangement in Non-Small Cell Lung Cancer With Sensitivity to Tyrosine Kinase Inhibitors: A Case Report.

Chunlai Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.